Price
No data yet.
Social Signal Score
Revenue
$1.94B+31.41%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Shao-Ning Chou
- Sector
- Industrials
- Industry
- Trucking
- Employees
- 3,572
- Beta
- 0.86
- Country
- CN
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -4.03
Financials
Revenue
$1.94B+31.4%Net Income
$-160.93MEBITDA
$-159.55MFree Cash Flow
$-138.52MEPS (diluted)
$-173.80Shares Outstanding (diluted)
925.5K-2.0%Operating Expenses
$249.65MCash & Debt
$294.67MReturn of Capital
$0.00Revenue by Segment (annual)
$2.88BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2023 | $8.32B | $-814.40M | $-870.00 |
| 2022 | $7.74B | $-1.46B | $-1498.40 |
| 2021 | $11.43B | $-1.26B | $-1301.00 |
| 2020 | $30.00B | $-1.68B | $-1744.20 |
| 2019 | $35.18B | $-218.71M | $-225.20 |
| 2018 | $27.96B | $-507.99M | $-528.60 |
| 2017 | $19.99B | $-1.23B | $-1311.40 |
| 2016 | $8.84B | $-1.36B | $-1444.40 |
| 2015 | $5.26B | $-1.06B | $-1122.40 |
| 2014 | $3.07B | $-718.46M | $-761.00 |
Valuation
BESThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newsglobenewswire.com·6h ago·Positive
Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences Topline data from Phase 1/2 Cohort 1 of OPGx-BEST1 gene therapy program to be presented during investor conference call and webcast on September 9 at 8:00 a.m. ET Full clinical dataset and additional analyses evaluating key measures of visual function to be presented at upcoming medical meetings RESEARCH TRIANGLE PARK, N.C.
View source ↗
Earnings
Typical surprise -31.6% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Mar 27$-1.00 vs $-0.76miss
Estimates and results for BEST via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BEST officers and directors.
No open-market trades in the recent filings. All 3 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
3 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.